NCT02684409View on ClinicalTrials.gov

Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Acute Migraine
Interventions
DRUG

PROT-CL-NP101-015.01

Sponsors

Lead Sponsor

NuPathe Inc.
All Listed Sponsors
lead

NuPathe Inc.

INDUSTRY